We next examined both BRG1 protein and SMARCA4 gene expression levels in normal prostate epithelial cells (PrEC) and compared to LNCaP (lymph node metastasis), an androgen-sensitive prostate cancer cell line, as well as PC3 (bone metastasis), an androgen-insensitive prostate cancer cell line. This evidence concerns the gene SMARCA4 and prostate cancer.